| 2.3 |
9.2 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 1.5 |
4.4 |
GO:0048818 |
embryonic nail plate morphogenesis(GO:0035880) positive regulation of hair follicle maturation(GO:0048818) positive regulation of catagen(GO:0051795) frontal suture morphogenesis(GO:0060364) |
| 1.4 |
5.6 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 1.3 |
4.0 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 1.0 |
1.9 |
GO:0072179 |
nephric duct formation(GO:0072179) |
| 0.8 |
2.5 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 0.8 |
3.2 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.8 |
2.3 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.6 |
1.7 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.5 |
1.5 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.5 |
2.8 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.4 |
1.3 |
GO:2000040 |
regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 0.4 |
2.4 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.4 |
0.8 |
GO:0061218 |
negative regulation of mesonephros development(GO:0061218) regulation of branch elongation involved in ureteric bud branching(GO:0072095) mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.4 |
3.0 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.4 |
2.1 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.3 |
1.0 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.3 |
2.8 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.3 |
0.9 |
GO:1905065 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.3 |
0.9 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) regulation of vascular wound healing(GO:0061043) glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.3 |
1.1 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.3 |
0.8 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.3 |
1.6 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.3 |
2.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.3 |
0.8 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.2 |
6.8 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.2 |
1.7 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 |
1.9 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.2 |
3.3 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 |
0.6 |
GO:0008228 |
opsonization(GO:0008228) modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.2 |
0.4 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 |
0.6 |
GO:0090526 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.2 |
2.4 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.2 |
0.7 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.2 |
0.7 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.2 |
0.7 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.2 |
0.8 |
GO:0015692 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.2 |
4.3 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.2 |
1.7 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.2 |
1.1 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.4 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
1.0 |
GO:0032782 |
urea transport(GO:0015840) bile acid secretion(GO:0032782) urea transmembrane transport(GO:0071918) |
| 0.1 |
0.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.7 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.1 |
0.3 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) alveolar secondary septum development(GO:0061144) |
| 0.1 |
0.7 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.1 |
1.5 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
0.8 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.1 |
0.6 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.1 |
1.1 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.1 |
0.5 |
GO:0060690 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) |
| 0.1 |
2.5 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
2.0 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
0.3 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.1 |
0.6 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.1 |
0.8 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.1 |
0.6 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.1 |
0.5 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.1 |
0.4 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.1 |
1.0 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.3 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.1 |
0.3 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) hard palate development(GO:0060022) |
| 0.1 |
0.2 |
GO:1902915 |
progesterone receptor signaling pathway(GO:0050847) negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
0.6 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.1 |
1.8 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.1 |
4.0 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.1 |
0.2 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
0.9 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.1 |
0.8 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.1 |
0.6 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.1 |
0.2 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 0.1 |
1.0 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
1.0 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.1 |
1.8 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
0.5 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.7 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
1.9 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.1 |
0.3 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
1.1 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
1.7 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.0 |
0.5 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.0 |
0.3 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.0 |
0.9 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.0 |
0.3 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.0 |
0.1 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.0 |
2.2 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.0 |
0.2 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.8 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.7 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.4 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.0 |
0.2 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.5 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.0 |
0.2 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.0 |
0.2 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.3 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
2.1 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.0 |
0.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.0 |
0.7 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
3.2 |
GO:0030178 |
negative regulation of Wnt signaling pathway(GO:0030178) |
| 0.0 |
0.3 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 |
0.2 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.1 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 |
0.3 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.4 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.0 |
0.1 |
GO:1900272 |
negative regulation of long-term synaptic potentiation(GO:1900272) |
| 0.0 |
3.5 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
0.6 |
GO:0019915 |
lipid storage(GO:0019915) |
| 0.0 |
0.6 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.2 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.0 |
1.3 |
GO:0030168 |
platelet activation(GO:0030168) |
| 0.0 |
0.5 |
GO:0061028 |
establishment of endothelial barrier(GO:0061028) |
| 0.0 |
0.7 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.0 |
0.7 |
GO:0008543 |
fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.0 |
1.2 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.0 |
0.1 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.0 |
1.0 |
GO:0060349 |
bone morphogenesis(GO:0060349) |
| 0.0 |
0.2 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.5 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.2 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) regulation of mitotic spindle assembly(GO:1901673) |
| 0.0 |
0.8 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.4 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.0 |
0.5 |
GO:0046676 |
negative regulation of insulin secretion(GO:0046676) |
| 0.0 |
0.2 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.0 |
0.3 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
0.1 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.0 |
1.5 |
GO:0098656 |
anion transmembrane transport(GO:0098656) |
| 0.0 |
0.1 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
